These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37641170)

  • 1. CRISPR/Cas systems for in situ imaging of intracellular nucleic acids: Concepts and applications.
    Chen K; Wang Y
    Biotechnol Bioeng; 2023 Dec; 120(12):3446-3464. PubMed ID: 37641170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Application of CRISPR/Cas-based biosensors for detecting nucleic acid of pathogens].
    Liu T; Tian Y; Liu C; Fang S; Wu Y; Wu M; Li B; Yang H; Liu Q
    Sheng Wu Gong Cheng Xue Bao; 2021 Nov; 37(11):3890-3904. PubMed ID: 34841793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges and Opportunities for Clustered Regularly Interspaced Short Palindromic Repeats Based Molecular Biosensing.
    Bao M; Chen Q; Xu Z; Jensen EC; Liu C; Waitkus JT; Yuan X; He Q; Qin P; Du K
    ACS Sens; 2021 Jul; 6(7):2497-2522. PubMed ID: 34143608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiplexed Detection Strategies for Biosensors Based on the CRISPR-Cas System.
    Wei C; Lei X; Yu S
    ACS Synth Biol; 2024 Jun; 13(6):1633-1646. PubMed ID: 38860462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point-of-care CRISPR/Cas nucleic acid detection: Recent advances, challenges and opportunities.
    van Dongen JE; Berendsen JTW; Steenbergen RDM; Wolthuis RMF; Eijkel JCT; Segerink LI
    Biosens Bioelectron; 2020 Oct; 166():112445. PubMed ID: 32758911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel nucleic acid detection strategies based on CRISPR-Cas systems: From construction to application.
    Zhu CS; Liu CY; Qiu XY; Xie SS; Li WY; Zhu L; Zhu LY
    Biotechnol Bioeng; 2020 Jul; 117(7):2279-2294. PubMed ID: 32175589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-Generation Diagnostic with CRISPR/Cas: Beyond Nucleic Acid Detection.
    Bhardwaj P; Kant R; Behera SP; Dwivedi GR; Singh R
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating CRISPR/Cas within isothermal amplification for point-of-Care Assay of nucleic acid.
    Zhang L; Jiang H; Zhu Z; Liu J; Li B
    Talanta; 2022 Jun; 243():123388. PubMed ID: 35303554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in biosensing: The CRISPR/Cas system as a new powerful tool for the detection of nucleic acids.
    Bonini A; Poma N; Vivaldi F; Kirchhain A; Salvo P; Bottai D; Tavanti A; Di Francesco F
    J Pharm Biomed Anal; 2021 Jan; 192():113645. PubMed ID: 33039910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of CRISPR-enabled biosensors for amplification-free nucleic acid detection.
    Talebian S; Dehghani F; Weiss PS; Conde J
    Trends Biotechnol; 2024 Jan; 42(1):10-13. PubMed ID: 37516612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress and Challenges for Live-cell Imaging of Genomic Loci Using CRISPR-based Platforms.
    Wu X; Mao S; Ying Y; Krueger CJ; Chen AK
    Genomics Proteomics Bioinformatics; 2019 Apr; 17(2):119-128. PubMed ID: 30710789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR Cas system: A strategic approach in detection of nucleic acids.
    Fapohunda FO; Qiao S; Pan Y; Wang H; Liu Y; Chen Q; Lü P
    Microbiol Res; 2022 Jun; 259():127000. PubMed ID: 35338974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microfluidics: the propellant of CRISPR-based nucleic acid detection.
    Chen Y; Qian S; Yu X; Wu J; Xu J
    Trends Biotechnol; 2023 Apr; 41(4):557-574. PubMed ID: 35989112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research advances on the development and application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein system].
    Tan JJ; Peng YZ; Huang GT
    Zhonghua Shao Shang Za Zhi; 2021 Jul; 37(7):681-687. PubMed ID: 34304411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal amplification and output of CRISPR/Cas-based biosensing systems: A review.
    Wang SY; Du YC; Wang DX; Ma JY; Tang AN; Kong DM
    Anal Chim Acta; 2021 Nov; 1185():338882. PubMed ID: 34711321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas-Based Diagnostics in Agricultural Applications.
    Tanny T; Sallam M; Soda N; Nguyen NT; Alam M; Shiddiky MJA
    J Agric Food Chem; 2023 Aug; 71(31):11765-11788. PubMed ID: 37506507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of CRISPR/Cas systems in the nucleic acid detection of pathogens: a review].
    Li M; Qin Z; Yin K; Zheng B
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2023 Feb; 35(1):98-103. PubMed ID: 36974023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/cas systems redefine nucleic acid detection: Principles and methods.
    Wang M; Zhang R; Li J
    Biosens Bioelectron; 2020 Oct; 165():112430. PubMed ID: 32729545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances and challenges of the use of the CRISPR/Cas system as a non-nucleic acid molecular diagnostic.
    Zhou J; Ren XM; Wang X; Li Z; J Xian C
    Heliyon; 2023 Dec; 9(12):e22767. PubMed ID: 38076202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas Biochemistry and CRISPR-Based Molecular Diagnostics.
    Weng Z; You Z; Yang J; Mohammad N; Lin M; Wei Q; Gao X; Zhang Y
    Angew Chem Int Ed Engl; 2023 Apr; 62(17):e202214987. PubMed ID: 36710268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.